The QualityStocks Daily Newsletter for Wednesday, Dec. 22nd 2010 Blog  |  Video  |  Market Basics  |  Quotes & News  |  Clients  |  Partners  |  About Us  |  Contact Us

Today's Top 3 Investment Newsletters


Stock Traders Chat (TMSH)


Nebula Stocks (GBHL)


CoolPennyStocks (NEOM)

The QualityStocks Daily

Deerfield Capital Corp. (DFR)

Today we are highlighting Deerfield Capital Corp. (DFR), here at the QualityStocks Daily Newsletter.

Deerfield Capital Corp., through their subsidiaries, Deerfield Capital Management LLC (DCM) and Columbus Nova Credit Investments Management, LLC, (CNCIM) is a top-performing credit asset management firm. The Company focuses on leveraged bank loans, high yield bonds, residential mortgage backed securities, government securities, and asset backed securities. Deerfield Capital Corp. trades on the NASDAQ Capital Market. They have their headquarters in Rosemont, Illinois.

The Company provides fixed-income investment management services to global investors.  Their investment management activities are conducted through Deerfield Capital Management LLC (DCM) and Columbus Nova Credit Investments Management LLC (CNCIM) and they have $9.4 billion assets under management (AUM) as of December 1, 2010.

The Company has approximately 65 employees.  Approximately one third are investment professionals.  DCM is registered with the Securities and Exchange Commission as an investment adviser and with the Commodity Futures Trading Commission as a commodity-trading advisor.

Through DCM, the Company manages 30 structured products. Sixteen of the structured products are CLOs that invest mainly in bank loans. Ten are CDOs that invest mainly in asset-backed securities. Four are CDOs that invest mainly in corporate bonds. They have managed various other types of investment products, including separately managed accounts and hedge funds.

In July 2008, they acquired the management contract for Robeco CDO II Limited, a CDO collateralized primarily by high yield corporate bonds. In February 2009, they assumed the management contract for Mayfair Euro CDO I B.V., a Euro-denominated CDO collateralized primarily by investment grade and high-yield corporate bonds. In June 2010, they acquired Columbus Nova Credit Investments Management LLC, an investment manager with four CLOs under management.

Yesterday, Deerfield Capital Corp. (DFR) and Commercial Industrial Finance Corp. (CIFC) announced their entry into a definitive agreement pursuant to which CIFC will merge with DFR.  Following consummation of the merger, Peter Gleysteen, the Chief Executive Officer of CIFC, will become the Chief Executive Officer, and Jonathan Trutter, the Chief Executive Officer of DFR, will become Vice Chairman of the combined company. The combined company will have their headquarters in New York and maintain operations in Chicago.  The merger, which is subject to various closing conditions, including approval by DFR's stockholders, is expected to close in the first part of 2011.

Commenting on the transaction, Jonathan Trutter said, "The combination of DFR and CIFC will create one of the world's largest structured credit and leveraged finance investment managers.  Combining the two companies will allow management to focus on implementing the best attributes from both companies."

Deerfield Capital Corp. (DFR) closed Wednesday's trading at $5.82, up 14.57%, on 52,103 volume with 195 trades.  The average volume for the last 60 days is 11,934.  The 52-week low/high is $3.75/$7.23.

EasyLink Services International Corporation (ESIC)

Investor Update reported earlier on EasyLink Services International Corporation (ESIC), and we report on the Company today, here at the QualityStocks Daily Newsletter.

EasyLink Services International Corporation is a global provider of value added services that facilitate the electronic exchange of documents and information between enterprises, their trading communities, and their customers. The Company delivers most of their services through a global IP network, which hosts their applications on enterprise-class platforms comprised of server and network operations centers located worldwide. EasyLink Services International Corporation lists on the NASDAQ Capital Market and they have their headquarters in Norcross, Georgia.

The Company's core services include EDI services, fax services, telex services, and other services integral to the movement of money, materials, products, people, and information in the global economy. This includes documents such as insurance claims, trade and travel confirmations, purchase orders, invoices, shipping notices, and funds transfers that help the Company's customers be more efficient and mobile.

Their operations include two business segments: Supply Chain and On Demand. The Supply Chain segment includes all their EDI and telex services. The On Demand segment includes all fax, e-mail, DCM, workflow and Notify (which includes the acquired Xpedite Business) services.

On October 21, 2010, EasyLink Services International Corporation acquired the iSend and iNotify advanced messaging businesses (the Xpedite Business) from Premiere Global Services, Inc. (PGI) for $105 million in cash, through the purchase of PGI's wholly-owned subsidiaries Xpedite Systems, LLC, and Premiere Global Services (UK) Limited and certain related assets owned by PGI's subsidiary Premiere Conferencing (Canada) Limited.

The expectation is that the Xpedite Business will significantly increase the Company's revenue in their On Demand segment, with related impacts on the cost of revenue and other items in their results of operations, compared to prior periods. The integration of the Xpedite Business and the servicing of the acquisition debt will be important drivers of their financial results in future reporting periods.

EasyLink Services has grown their business significantly through acquisitions in recent years. They continue to seek to reap the benefits of those acquisitions through the integration and consolidation of operations and the cross selling of services across the combined customer base.

EasyLink Services International Corporation provides their services to customers in various industries. These include professional services, financial services, manufacturing, mining, retail, distribution, freight services, insurance, and telecommunications.

EasyLink Services International Corporation (ESIC) closed Wednesday's trading session at $4.23, up 1.93%, on 81,300 volume with 226 trades.  The average volume for the last 60 days is 116,544.  The 52-week low/high is $1.63/$4.53.

Escalade Inc. (ESCA)

Today we are reporting on Escalade Inc. (ESCA), here at the QualityStocks Daily Newsletter.

Escalade Inc. is a manufacturer and marketer of sporting goods and office/graphic arts products sold globally. The Company sells their office products to office products retailers, wholesalers, and catalog distributors. Escalade Inc. lists on the NASDAQ Global Market. They have their corporate headquarters in Evansville, Indiana.

The Company's roots date back to the year 1922. In that year, the Williams Manufacturing Company, an Ohio based manufacturer and retailer of women and children's footwear formed. In 1972, they merged with Martin Yale Industries, Inc., an Illinois manufacturer of office and graphic arts products; and leisure time items such as toys and hobby/craft items.

In 1992, Escalade International, Ltd. was established in the United Kingdom to distribute sporting goods products in Europe. In 1999, they sold 50 percent interest in Escalade International, Ltd. to a management group who assumed all responsibilities for day-to-day operations.

Escalade Inc. operates through their two wholly owned subsidiaries: Escalade Sports and Martin Yale. Escalade Sports manufactures and sells a variety of sporting goods. These include table tennis, pool and game tables; basketball hoops; darts and accessories; archery/bow hunting equipment; wooden swing sets and personal fitness products. Escalade Sports sells their products through quality retailers and sports specialty stores. They do so utilizing strong, well-recognized brand names such as Stiga®, Ping Pong®, Harvard®, Goalrilla®, and Woodplay®.

Martin Yale is a multinational manufacturer and distributor of a broad spectrum of office products. These include paper folding machines, paper cutters/trimmers, paper hole punches, data shredders, and office accessories such as keyboard drawers and copyholders. Brands include Martin Yale®, Premier®, Master®, Intimus®, and Mead Hatcher®. Martin Yale sells their products through a combination of distributors and office supply retailers.

In November, Escalade, Inc. announced that the Company's Board of Directors authorized the payment of a ten cents ($0.10) per share dividend payable December 6, 2010, to all shareholders of record on November 22, 2010.

"This dividend of $0.10 per share reflects the significant improvement in operating results and debt reduction since 2008," stated Robert J. Keller, President and Chief Executive Officer of Escalade Inc. "Management believes 2010 profits will generate sufficient cash flows to pay dividends, meet operating capital requirements, and invest in strategic growth initiatives, including product innovation and brand marketing."

Escalade Inc. (ESCA) closed Wednesday's trading session at $6.10, down 2.40%, on 49,220 volume with 236 trades.  The average volume for the last 60 days is 11,330.  The 52-week low/high is $2.06/$6.65.

Fresh Start Private Management Inc. (CEYY)

Stock Traders Chat, Bull Rally, Cool Penny Stocks, Stock Egg, Stock Rich, and Hot OTC reported this week on Fresh Start Private Management Inc. (CEYY), and we highlight the Company today, here at the QualityStocks Daily Newsletter.

Fresh Start Private Management Inc. is an alcohol addiction, alcohol withdrawal; alcohol abuse treatment and alcohol detox Rehabilitation Company on the leading edge of alcohol addiction treatment. The Company has licensed a highly effective treatment that delivers target therapeutic levels of Naltrexone that significantly reduce patients' cravings for alcohol. Fresh Start Private Management Inc. has their headquarters in Santa Ana, California.

The Company has significant experience in alcohol addiction treatment and they successfully treated more than 5,000 addiction patients (both drug and alcohol). They have created a uniquely comprehensive alcohol treatment program that incorporates all of the essential elements for successful alcohol addiction recovery.

Fresh Start Private is the only alcohol treatment program to offer a single-administration, licensed long acting, Naltrexone implant procedure. Naltrexone has approval for use by the FDA within the United States for the treatment of alcohol.

Trained medical doctors - at an independent clinic, which forms part of the Company's network in America -insert a specially formulated, biodegradable naltrexone implant just beneath the skin below the patient's lower abdominal area. The procedure is rapid and requires only local anesthetic. The implant significantly reduces one's cravings for alcohol. It gives them the opportunity to deal with their alcohol addiction without wanting a drink.

The patented product is a state-of-the-art medical procedure. The procedure can last up to one year. There is no downtime for alcohol addiction treatment. A patient can return home and resume work the same day. The Company's procedure tackles the physical aspect of alcoholism. They offer continuing care for patients and family upon return home.

The Fresh Start Coaching Program is conducted through a series of private sessions. They involve only the patient, their accompanying recovery partner, and the treatment professional.

In late November, Fresh Start Private announced that their first facility is operational. The facility is able to treat up to 15 patients a day with potential revenue of $120 Million per year per clinic. Their fully licensed and certified medical facility has three treatment rooms that are each able to process up to five patients per day.

Earlier this month, Fresh Start Private Management Inc. provided data showing that Naltrexone is effective in the treatment of alcoholism. According to published results in the Oxford Journals, research indicated, "Naltrexone is superior to placebo. Subjects treated with Naltrexone experience significantly fewer episodes of relapse, and significantly more remain abstinent when compared to placebo-treated subjects {risk difference of relapse rates = -14% [95% confidence interval (CI): -23%, -5%]; and risk difference of abstinence rates = 10% (95% CI: 4%, 16%)} after 12 weeks of treatment. The Naltrexone-treated subjects also consume significantly less alcohol over the study period than do placebo-treated subjects."

Fresh Start Private Management Inc. (CEYY) closed Wednesday's trading at $0.165, up 55.66%, on 542,096 volume with 80 trades.  The average volume for the last 60 days is 118,835.  The 52-week low/high is $0.021/$0.95.

Helix Wind, Corp. (HLXW)

OTC Picks and Investor Voice reported recently on Helix Wind, Corp. (HLXW), OTC Picks, PennyTrader Publisher, Bull Rally, Stock Rich, Hot OTC, Cool Penny Stocks, Stock Twiter, Stock Source, Microcap Voice, Nebula Stocks, Penny Omega, Greenbackers, Level Stock, Penny Trader did earlier, and we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Helix Wind, Corp. engages in the small wind turbine alternative energy business. The Company offers a distributed power technology platform designed to produce electric energy from the wind. Helix Wind has primarily engaged in the research and development of their proprietary products. Trading on the OTCBB, the Company engages in the design, manufacturing, and sale of small wind vertical axis turbines designed to generate 300W, 1kW, 2.0kW, and 4.0kW of clean, renewable electricity. Incorporated in 2006, Helix Wind, Corp. has their headquarters in San Diego, California.

The Company serves residential, commercial, governmental, educational, industrial, and agricultural sectors. The Company also serves developers, architects, and engineers. They market and sell their products directly to end users and certified distributors, as well as through indirect or channel sales with certified distributors in the U.S. and globally.

They offer their wind turbines to generate energy utilizing wind for residential and commercial applications. They also focus on offering turbines for liquid pumping in the petroleum industry for injection pumping at off grid and remote locations, and the water pumping industry for off grid drinking water and agricultural applications, as well as for cell tower installations and digital billboards.

The Helix system is inexpensive, reliable, and simple. This makes it a quality choice for low wind speed residential and commercial applications. The Savonius turbine based design catches wind from all directions creating smooth powerful torque to spin the electric generator. Mounted up to 35 feet high, in winds as low as 10 mph, the Helix system creates electricity to power a home or business.

As the wind blows, the long helical blade scoops catch wind from all directions forcing it through the turbine. The turbine generator is connected directly to a home and as electricity is generated, the home is powered. If the wind isn’t blowing, the home is powered by the energy grid as usual. If the wind is blowing strongly then the energy produced can exceed the energy consumed and, depending on one's local utility, their meter can spin backwards rolling back their energy bill.

Small wind energy systems are one of the fastest growing forms of customer-sited or “distributed” electric generation. They are one of the best energy investments for small businesses and homeowners. Small or “residential” wind energy systems normally generate just enough power to meet the demands of a home, farm, or small business. They range from 400 watts to 500 kilowatts or more and typically consist of a single turbine (vertical or horizontal). They can be significant power sources and have proven records of performance, even in locations with modest winds.

The success of the commercial wind industry has propelled significant advances in small turbine design, making these systems more reliable, quieter, and safer than those introduced in past decades. Most of the electricity they produce is used on-site. However, excess generation can be fed into distribution lines, strengthening the electric grid.

Helix Wind, Corp. (HLXW) closed Wednesday's session at $0.0012, up 9.09%, on 150,267,121 volume with 269 trades.  The average volume for the last 60 days is 23,313,312.  The 52-week low/high is $0.001/$2.70.

Neurokine Pharmaceuticals Inc. (NEUKF)

Today we are highlighting Neurokine Pharmaceuticals Inc. (NEUKF), here at the QualityStocks Daily Newsletter.

Neurokine Pharmaceuticals Inc. is a development-stage biopharmaceutical company that lists on the OTC Bulletin Board. They engage in the development and commercialization of therapeutic pharmaceutical products. The Company's strategic emphasis is on research and development to innovate applications for existing drugs - commonly known as drug re-profiling. Founded in 2002, Neurokine Pharmaceuticals Inc. has their corporate headquarters in Vancouver, British Columbia.

The Company's research and development activities focus on assessing known drugs and compounds, developing hypotheses concerning their usage for new indications (diseases), and conducting experimentation and clinical research to test those hypotheses. They intend to depart from a strict re-profiling strategy to develop new variants of, or delivery methods for, existing drugs or compounds. This is as is appropriate, based on their research.

Neurokine Pharmaceuticals Inc.'s business model currently includes identifying new indications for approved and marketed products, and securing intellectual property rights to those products. Their business model also includes conducting preliminary laboratory tests and clinical trials; and establishing partnerships with large pharmaceutical and biotechnology companies to develop and commercialize products outside of their initial market focus.

The Company currently has identified the first three anti-inflammatory products:  NK001, NK002, and NK-003 with promising prospects for the treatment of neurocognitive impairment and discogenic back pain conditions.  Neurokine is also developing proprietary encapsulation technology to allow better blood brain barrier penetration to initiate and enhance therapeutic effects of anti-inflammatory drugs in the treatment of neurodegenerative diseases.

Neurokine focuses on biologics comprising vaccines, blood, and blood components; allergenics; somatic cells relating to the wall of the body cavity; gene therapy; tissues; and recombinant therapeutics that causes cell death in tumors.

Their goal is to develop and commercialize approved drugs outside their initial marketed focus. Neurokine addresses diseases and ailments not well served by currently available therapies and that represent large potential commercial opportunities.

Earlier this month, Neurokine Pharmaceuticals Inc. announced the completion of their new clinical trials plan to test the effects of NK-001 in the treatment of Alzheimer's type memory loss in patients undergoing coronary artery bypass graft (CABG) surgery. The plan will be to carry out clinical trials in 50 patients following CABG surgery and to test these patients for up to 12 months following surgery for cognitive impairment (similar to Alzheimer's). The patients will be divided in two groups; 25 will receive NK-001 and 25 will receive placebo.

Neurokine Pharmaceuticals Inc. (NEUKF) closed Wednesday's trading session at $1.39, up 31.13%, on 44,354 volume with 45 trades.  The average volume for the last 60 days is 2,114.  The 52-week low/high is $0.51/$2.55.

Sport Endurance, Inc. (SENZ)

Stock Rock and Roll reported recently on Sport Endurance, Inc. (SENZ). Open Water Investments, Simply Best Penny Stocks, Top Best Pennystocks, Penny Invest, OTC Picks, Stock Mister, Bull Rally, Stock Rich, Hot OTC, Cool Penny Stocks, Penny Invest, Stock Egg, Penny Stock Explosion, 24-7 Stock Alert, Global Equity Report, PennyStockRumors.net did earlier. The Stock Psycho, Topgun Stockpicks, quick-investments.com, Stock Exploder, Stock Stars, Stockpalooza, OTC Reporter, SmallCap Voice, Market Wrap Daily, and Stock Market News Alert also reported earlier, and we highlight the Company, here at the QualityStocks Daily Newsletter.

Sport Endurance, Inc. is a Nevada corporation that lists on the OTC Bulletin Board. The Company intends to manufacture and distribute a line of sports energy drinks. Production and distribution has not yet commenced. Therefore, the Company is considered to be in the development stage. Sport Endurance, Inc. has their headquarters in Salt Lake City, Utah.  

The Company is an innovative and rapidly growing provider of high quality nutritional and dietary supplements. They are targeting health issues that include energy and weight loss, muscle growth, and sleep. They are the first to offer pharmaceutical grade gel cap forms of increasingly popular energy products and energy shots.

In addition to their Energy Liquid Gel Cap, their product line includes complimentary products focusing on muscle mass and sleep/ relaxation, creating a comprehensive health and lifestyle brand, with additional product launches planned into the intermediate term.

They have launched an aggressive distribution and marketing strategy with the goal of reaching distribution to more than 100,000 national retail locations within the next twelve months. Their recent distribution agreement with Mr. Checkout Distributors is significant for the Company. It will place the Sport Endurance product line in approximately 15,000 locations over the next fiscal quarter.

They are working to establish a profitable niche for the Company in the lucrative $10 billion “energy” product market and the $68 billion nutritional supplement space. The Company believes that they are well positioned to attain national distribution of their products within the year, and attain substantial, accretive revenue and earnings growth into 2011 and beyond, as their products gain exposure. They anticipate that they will top revenues of $7.4 million in 2011 with positive earnings, attaining annual revenues in excess of $38.7 million by 2013.

Sport Endurance Sleep Aid is designed to help users get the rest they need. This can benefit one’s learning and memory, metabolism and weight, mood, and cardiovascular health. It is also designed to help strengthen the immune system. Their sleep aid product complements their creatine product.

Sport Endurance's Liquid Creatine Gel Caps contain Creatine as its main ingredient. Creatine derives from Kre-Alkalyn. Kre-Alkalyn allows one to safely consume creatine to its full and most potent level with only a fraction of previous dosages. It is free of unwanted creatinine conversion following liquid activation. The Company's formulation also includes L-Leucine, L-Glutamic Acid, and L- Arginine for optimal performance.
Along with their sleep aid and creatine products is their Sport Endurance 8-Hour Energy. It is formulated with ingredients that work with the body to increase metabolism, maintain energy, burn fat, increase self-confidence and have a more positive attitude and energetic approach to life. Sport Endurance products all use a state of the art soft gel capsule delivery system allowing rapid absorption, no calories, and no taste and quality assurance.

In October, Sport Endurance, Inc. announced that they have begun development on a new weight loss gel cap to add to their existing line of successful liquid gel cap products. The new innovative weight loss product will be developed using the most natural, organic ingredients.

Sport Endurance, Inc. (SENZ) closed Wednesday's session at $0.023, up 318.18%, on 7,379,335 volume with 268 trades.  The average volume for the last 60 days is 958,336.  The 52-week low/high is $0.0051/$1.0777.

Worlds.com Inc. (WDDD)

Today we are highlighting Worlds.com Inc. (WDDD), here at the QualityStocks Daily Newsletter.

Worlds.com is a leading 3D entertainment portal, which leverages their proprietary technology to offer visitors a network of virtual, multi-user environments, which the Company calls "worlds". These worlds are visually engaging online environments featuring animation, motion, and content where people can come together and, by navigating through the website, shop, interact with others, attend events, and be entertained. Worlds.com Inc.'s shares trade on the OTC Bulletin Board. The Company has their corporate headquarters in Brookline, Massachusetts.

Sites using the Company's technology allow numerous simultaneous visitors to enter, navigate, and share interactive "worlds". The design of their 3D Internet sites are to promote frequent, repeat, and prolonged visitation by users by providing them with unique online communities featuring dynamic graphics, highly useful and entertaining information content, and interactive capabilities.

Launching in 1994, Worlds takes advantage of their patented proprietary technology in partnership with brand leaders in specific market segments to offer members multi-user environments. These environments have interactive Avatars, rich media graphics, text chat, voice-to-voice chat, video, and e-commerce. Worlds also encourages individuals to create their own virtual spaces, communities, and unique Avatars with easy-to-use tools.

Their technology enables the development of virtual worlds, which have various applications. These include a virtual meeting place, such as a fan club; a 3D e-commerce store to view merchandise in 3D and purchase it online; and a virtual classroom to view content via video streaming and then discuss about the content in real time. They also operate Worlds Ultimate 3D Chat, a proprietary online 3D Internet chat site for the music industry and fans.

Worlds.com Inc. believes that their sites are highly attractive to advertisers because they offer access to demographic-specific user bases comprised of people that visit the site frequently and stay for relatively long periods. The revenue that the Company generated in the last quarter was generated from VIP subscriptions to their Worlds Ultimate 3-D Chat service, as well as from licensing fees for their technology.

The Company's net revenues for each of the three months ended September 30, 2010 and 2009 were $150,078 and $10,374, respectively. Their net revenue for each of the nine months ended September 30, 2010 and 2009 were $225,652 and $100,967, respectively. The increase in revenue is due to an increase in licensing revenue.

Worlds.com Inc. (WDDD) closed Wednesday's trading session at $0.13, up 18.18%, on 475,499 volume with 37 trades.  The average volume for the last 60 days is 22,715.  The 52-week low/high is $0.024/$0.27.

The QualityStocks Company Corner

IDO Security Inc. (IDOI)

The QualityStocks Daily Newsletter would like to spotlight IDO Security Inc. (IDOI). Today, IDO Security Inc. closed trading at $0.0009 on 37,994,331 volume with 172 trades.  The average 60-day volume is 48,877,565 with a 52-week low/high of $0.0004/$0.013.

IDO Security, Inc. (IDOI), headquartered in New York with a subsidiary in Israel, focuses on developing solutions for shoes-on weapons metal detection. The company's flagship product, the patented MagShoe™ system, instantly and accurately detects metal items concealed on or in footwear, ankles or feet without requiring the removal of shoes. Taking only 3-4 seconds to scan, the detection system solves possibly the most problematic issue in the security checkpoint routine.

The MagShoe is produced at the company's main manufacturing facility in Rishon LeZion, Israel where it offers local sales and support via a worldwide network of industry-leading distributors and system integrators. Designed for security and loss prevention at high-security venues and checkpoints, IDO Security's products are currently in use at international airports, cruise lines, government agencies and other locations requiring strong security.

The company's detection systems employ state-of-the-art sensors and algorithms to detect weapons and other controlled metal articles. By providing accurate measurements, the MagShoe solutions keep false alarms at minimum - detecting potentially dangerous items while ignoring metal typically found in footwear such as heels, zippers and ornaments. The advanced technology reduces the number of manual inspections required, allowing personnel to focus on the real threat.

President and Director Michael L. Goldberg guides the direction of the company with an extensive business and legal background spanning more than 30 years. Prior to joining IDO Security, Mr. Goldberg spent 17 years as the Chairman, CEO and one-time President of RX Medical Services, a medical company that owned and operated small rural hospitals, clinical laboratories and MRI/CT centers across the US. He has served on the boards and as a member of audit and compensation committees for a number of public companies.

IDO Security Inc. (IDOI Blog

IDO Security Inc. News:

IDO Security Receives Letter of Intent From UK Distributor for First Multi-Site Order for New MagShoe 3G(TM) Series

IDO Security Answering Travelers' Outcries Demanding Safer and Less Invasive Security Screening Methods

IDO Security to Exhibit and Train Its Distributors on the New 3G and 3G/4 Models in China

Simulated Environment Concepts, Inc. (SMEV)

The QualityStocks Daily Newsletter would like to spotlight Simulated Environment Concepts, Inc. (SMEV). Today, Simulated Environment Concepts closed trading at $0.0071 on 315,832 volume with 20 trades.  The average 60-day volume is 549,680 with a 52-week low/high of $0.0051/$0.07.

Simulated Environment Concepts, Inc. (SMEV) is focused on manufacturing and distributing their patented SpaCapsule® as well as continued innovation in the areas of anti-aging, cosmetics, relaxation, cellulite reduction, and weight loss. Finding use in numerous environments such as relaxation centers, golf clubs, ski lounges, gyms, and health clubs, the SpaCapsule® provides next generation de-stressing and relaxation.

Simulated Environment Concepts, Inc. (SMEV) is focused on manufacturing and distributing their patented SpaCapsule® as well as continued innovation in the areas of anti-aging, cosmetics, relaxation, cellulite reduction, and weight loss. Finding use in numerous environments such as relaxation centers, golf clubs, ski lounges, gyms, and health clubs, the SpaCapsule® provides next generation de-stressing and relaxation.

The company’s founders, Dr. Ella Frenkel and Dr. Ilya Spivak, initially capitalized Simulated Environment Concepts Inc. with seve8ral million dollars of their own money. With this initial investment, the company worked on, and succeeded in developing, the sleek and stylish looking pressurized dry water massage relaxation station.

SpaCapsule® is a full body massage, aromatherapy, audio and video entertainment system. The capsules are fused with advanced modern technology and healing methods of aromatherapy and audiovisual relaxation techniques, incorporating proprietary water-jet and pressure-jet technology that requires no on-site plumbing. Weighing approximately 500 lbs, the capsule only requires standard electric service.

Simulated Environment Concepts, Inc. (SMEV) anticipates progressive and consistent growth over the next six years. With individuals spending billions of dollars on de-stressing, weight loss, anti aging, cosmetics, massage and physical rehabilitations, the company is in a position to experience explosive growth from current levels. Disclaimer

Simulated Environment Concepts, Inc. Blog

Simulated Environment Concepts, Inc. News:

SpaCapsule to See Holiday Season Sales On-Line As Hammacher-Schlemmer and FrontGate Featured Product

Simulated Environment Concepts Enthusiastic About 2011; Plans for Transparency, Additional Contracts, Increased Sales

SpaCapsule Medical Sales Surge with Increased Interest from Physicians and Physiotherapists

True 2 Beauty (TRTB)

The QualityStocks Daily Newsletter would like to spotlight True 2 Beauty (TRTB). Today, True 2 Beauty closed trading at $0.02101 on 148,850 volume with 34 trades.  The average 60-day volume is 218,044 with a 52-week low/high of $1.00/$0.02.

True 2 Beauty (TRTB) is a leading manufacturer and distributor of sexual potency pills and liquid products in the United States, with expansion efforts underway in other parts of the world. The company's line of current products currently include Libigrow (for men), Libigirl (for women), Libiliquid Shots and Libiliquid Relaxation Drinks. Made from only natural ingredients, the products are regarded as the most powerful over the counter herbal sexual and performance supplements available on the market.

In addition to being sold online, Libigrow products are sold throughout the U.S. in convenience stores, liquor stores, smoke shops, vitamin stores, independent grocers, and adult boutique stores, with potential in larger chains such as CVS, Walgreens and GNC to name a few. In fact, a major retail pharmacy chain has begun a regional trial in eight of their stores in southern Florida in preparation for a nationwide roll-out to begin in early 2011 for select Libigrow products – the first step to national expansion within the retail pharmacy chain network.

The company has recruited a trained and highly qualified full-time staff. In addition to their talented and well-seasoned designers, the company employs a team of photographers, web designers, a marketing and advertising director and assistant director, account managers in sales, in-house customer service representatives, a commercial ads designer and editor, and an in-house printing team for all promotional material.

Alex Hbaiu leads the company as CEO, president and director. He published several research articles and findings during his employment at Eli Lily Research Labs where he had the opportunity to work with some of the most talented and educated doctors and scientists in the world. Although founded with very little capital, via Mr. Hbaiu's expert leadership Librigrow has grown to over $10,000,000 in sales via "word of mouth" advertising alone. Disclaimer

True 2 Beauty Blog

True 2 BeautyNews:

True 2 Beauty, Inc. and Kretek International, Inc. Form Libigrow Team

True 2 Beauty Signs Balkan Countries License for "LibiGrow" Line of Products

A New Audio Interview with Alex Hbaiu, President and CEO of True 2 Beauty, Inc., is now at SmallCapVoice.com

Daulton Capital Corp. (DUCP)

The QualityStocks Daily Newsletter would like to spotlight Daulton Capital Corp. (DUCP). Today, Daulton Capital Corp. closed trading at $0.20 on 114,510 volume with 21 trades.  The average 60-day volume is 131,520 with a 52-week low/high of $0.10/$0.75.

Daulton Capital Corp. (DUCP) provided shareholders some commentary from the Yukon Gold Mining Alliance, which called the region one of the best and most exciting jurisdictions in the world in which to conduct mineral exploration and mining.

Daulton Capital Corp. (DUCP) is a natural resource finance company focused on precious and base metals as well as oil & gas opportunities. With the primary objective of partnering with major and junior natural resource companies for option/joint venturing projects, Daulton Capital has formed an experienced management team with the expertise necessary to capitalize on the tremendous opportunities available in the natural resource sector today.

Daulton Capital Corp. (DUCP) also aims to acquire resource projects and expand exploration while continuing to seek special situations and unique opportunities in under funded projects within the resource sector. When evaluating these opportunities, Daulton Capital keeps its primary focus on growing shareholder value while limiting investment risk. The company also commits itself to being responsible with integrity, trust and respect for all partners and communities involved.

Daulton Capital Corp. (DUCP) has negotiated an option agreement on two key Gold Projects located in the Yukon Territory, Canada; the Hunker Project, which is located in the heart of the famous Klondike Placer Gold District and the Balarat Project, located in the White Gold District. This newly discovered and internationally recognized area is the same district where Underworld Resource's (TSX.UW) recent drill results incepted grades of 103 meters averaging 3.4 g/t Au.

Both energy related resources such as natural gas and oil as well as precious metals such as gold, silver and copper will play a significant role in the growing demands of the world's economy. Taking into consideration the relative buoyancy of the price of precious metals and energy due to worldwide demand drivers, currency and economic turbulence, the outlook for the price of natural resources is quite favorable as demand continues to increase. Disclaimer

Daulton Capital Blog

Daulton Capital News:

Daulton Capital's Property Located in White Gold District of Yukon, Gathering Interest as Gold Climbs Past $1400 an Ounce

Daulton Capital Establishing Gold Exploration in Region That Favors Investment and Rewards

Daulton Capital's Proximity to Proven Gold Reserves Bodes Well as Precious Metal Prices Hit Record Highs

Developing Successful Technologies is Nothing New to Zentric, Inc. (ZNTR) Team

The management team leading Zentric Inc. has plenty of experience developing new technologies, as well as founding successful companies to develop and monetize those technologies.

• Mr. Jeff Mak, President, founder of several companies, has 20 years of experience in the design and technology industry. Among the companies he founded and led is Logicsys Technologies, once publicly traded on the CDNX with over $30 million in annual sales, and Eastgate Innovations, a product research and development company which owns several original patents with licensing to several other companies.

• Mr. Kwok Kwong Chan, Director, has spent 35 years in the electronics industry. Graduating in electrical engineering as well as business management, he has both product design and managerial experience, including top level manufacturing management covering 400 employees.

• Mr. Kwong-Yu Chan, Ph.D. – Science Adviser – obtained his doctorate in Chemical Engineering from Cornell University, and has held a number of positions at universities in both the U.S. and Asia. He has published over 120 papers on various topics in electrochemistry, physical chemistry, chemical engineering, and materials, with over 2000 citations. He has several inventions relating to fuel cells, ozone generation, hydrogen generation, and batteries, with U.S. patents issued. He is currently a Professor in the Department of Chemistry at the University of Hong Kong, and is a Regional Editor of the Journal of Experimental Nanoscience.

The ability to deal with the many challenges of introducing a new technology is critical to Zentric. The company, headquartered in Ontario, is developing a revolutionary battery that uses a combination of metal hydride and lead acid to achieve the power of the lithium-ion battery while maintaining the lower cost of traditional lead acid batteries.

For more information on Zentric, and their new battery technology, visit www.ZBatt.com

Norsat International, Inc. (NSATF) Product Used in ALPHA Study to Demonstrate Reliability

Norsat International Inc., a leading provider of broadband communications solutions, today announced that one of its Ka-Band BUCs was recently used in an antimatter study called the ALPHA (Antihydrogen Laser Physics Apparatus) experiment at the CERN Laboratory near Geneva, Switzerland.

ALPHA is an international collaboration consisting of 42 scientists from universities and institutes around the world, with 15 members from Canada. In this study, researchers at ALPHA for the first time caged antimatter atoms and kept them long enough to be studied by scientific instruments. In regards to Norsat’s BUC, the researchers are seeking a method to find out what colour light the antihydrogen shines when it is hit with microwaves.

In a letter signed by four members of the collaboration, the researchers stated, “The Norsat unit functioned exactly as specified, with the expected gain and a maximum power level of 5 watts, with the correct frequency shift (measured directly) and at the expected DC power drain. It was also determined that the gain of the unit was insensitive to magnetic fields, to at least 100 gauss, the maximum field tried (this was an important, but non-standard property of the unit, because of the relatively large fringing fields of the experiment).”

Dr. Amiee Chan, president and CEO of Norsat, said the use of its product in an ALPHA study demonstrates the product’s reliability. “It is quite refreshing to learn that one of our BUCs has been utilized in an antimatter study in the prestigious CERN Laboratory, which shows the reliability of our products, even in a research setting like this one which requires the utmost precision. The unit provided to ALPHA was a pre-production model and we look forward to offering the BUC commercially early in the new year,” Dr. Chan stated in the press release.

Norsat’s broadband communication solutions enable the transmission of data, audio and video in remote and austere environments; its services range from microwave components, portable satellite systems, maritime solutions and wireless network solutions to equipment financing.

Anavex Life Sciences (AVXL) Files Milestone Regulatory Submission for Alzheimer’s Treatment

Anavex Life Sciences Corp. today announced that it has filed the regulatory submission for its lead compound for the treatment of Alzheimer’s disease, ANAVEX 2-73, with the German Health Authority, BfArM, and the local Ethics Committee of Saxony.

The filing will enable the company to move forward with clinical studies for ANAVEX 2-73, and represents an integral achievement for Anavex.
“This regulatory filing marks an important milestone in the clinical development path for ANAVEX 2-73 and our strategy to aggressively complete a phase I and IIa study in healthy human volunteers and patients, respectively,” Dr. Cameron Durrant, executive chairman of Anavex stated in the press release.

The company will commence phase I dosing of healthy human volunteers with ANAVEX 2-73 in the near future; and a phase IIa study in patients with Alzheimer’s and Mild Cognitive Impairment may provide efficacy data and additional safety data, and is currently scheduled to commence in mid 2011.
“Our extensive pre-clinical program for ANAVEX 2-73 and the data generated so far offers the possibility of excellent safety and tolerability and encouraging signs of potential efficacy,” added Dr. Durrant.

Anavex is a biopharmaceutical company engaged in the discovery and development of novel drug candidates for the treatment of neurological diseases and cancer.

No News is Good News for IntelliPharmaCeutics International Inc. (IPCI)

Toronto, Canada-based Intellipharmaceutics International, Inc. released news this morning to report that it has not received any notification, as provided for under the Hatch-Waxman Act, of any patent infringement proceedings by Wyeth Pharmaceuticals, the brand owner of Protonix® and wholly-owned subsidiary of Pfizer, Inc. (NYSE:PFE), for its application to bring to market a generic version of Protonix® (delayed-release pantoprazole sodium) tablets. Intellipharmaceutics announced in October 2010 that the FDA had accepted for filing its Abbreviated New Drug Application (ANDA) for its generic version of Protonix®. Per ANDA protocol, Intellipharmaceutics informed Wyeth that it had submitted paragraph IV certifications of invalidity and non-infringement for the patents that cover Protonix®.

According to the Hatch-Waxman Act, Wyeth had 45 days to file patent infringement documentation, which, to the best of Intellipharmaceutics’ knowledge, it did not. Because there was no documentation of patent infringement, Intellipharmaceutics will not be subject to the automatic 30-month stay of FDA approval when such contentions are brought forth; leaving the Company free to bring the generic version of Protonix® to market upon FDA approval.

As with any FDA decision, there can be no assurance of FDA approval, but this news puts Intellipharmaceutics in a prime position if the generic is granted approval as a therapy to limit gastric acid secretion. Protonix® is also prescribed for the short-term treatment of conditions such as stomach ulcers associated with gastroesophageal reflux disease as well as the long term treatment of pathological hypersecretory conditions including Zollinger-Ellison syndrome, a rare disorder characterized by one or more tumors in the pancreas, duodenum, or both which cause the stomach to make too much acid. Protonix® generated $1.8 billion in sales for Wyeth in 2009 alone.

With several ANDA’s filed with the U.S. Food and Drug Administration, Intellipharmaceutics could be a play to keep an eye on in 2011. These ANDA’s are for generic versions of the extremely popular Focalin XR® (marketed by Novartis), Effexor XR® (marketed by Pfizer), and the aforementioned Protonix®. Additionally, Intellipharmaceutics possesses its patented Hypermatrix™ technology, which is a unique and validated multidimensional controlled-release drug delivery platform that can be applied to the efficient development of a wide range of existing and new pharmaceuticals. In its pipeline, the Company has several products in various stages based on the Hypermatrix™ technology that are being developed to address a variety of therapeutic areas including neurology, cardiovascular, GIT, pain and infection.

The Company has a miniscule share structure of less than 11 million shares issued and outstanding, less than five million shares in the float and a current market cap of under $30 million. When it comes to biotechnology stocks, there is always a degree of risk that is offset with large reward factor that sends biotech investors digging for companies with a large upside that are not in the mainstream of the general investment population. Intellipharmaceutics just may be one of those gems that captures significant attention in the upcoming year.

More information on Intellipharmaceutics International, its pipeline of products and the investment opportunity presented can be found on the Company’s website at www.intellipharmaceutics.com.


Sponsors of the Day


The QualityStocks Public Company Sponsor News

Micro Identification Technologies Inc. (MIT) (MMTC) MIT Reports a Successful Webinar Presentation of the Technologies and Operations of Its Bacterial Identification System



About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

Home | Blog | Video | Market Basics | Media | Partners | Clients | About Us | Contact Us | Disclaimer | Unsubscribe
Copyright 2006-2009 QualityStocks 3370 N. Hayden Rd. Suite 123-591 Scottsdale, AZ 85251 480-374-1336